CTRI/2012/01/002362已完成2 期
evaluation of preclinical toxicity of a siddha formulation kandhaga rasayanam and its therapeutic efficacy in padarthamarai(dermatophytoses) by an open clinical trial
试验速览
- 阶段
- 2 期
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients clinically diagnosed with tinea infection (tinea pedis, cruris, corporis, capitis, barbae, mannum ,ungium.).
- •Patients of both sexes. Patients between 18 years to 60 years of age.
- •Ability to understand and sign the informed consent.
- •Direct microscopic examination of the skin scraping which shows positive for dermatophytes.
排除标准
- •Pregnant women or nursing mother.
- •Use of other topical or oral antifungal drugs, immunosuppressive drugs, anthelmintic drugs either currently or during the 2 weeks preceding initiation of drug trial.
- •Allergy or hypersensitivity of any component of the drug.
- •Clinical case of Eczema, Psoriasis, Lichen planus, Pityriasis versicolor, Drug induced eruptions, Urticaria, Intertrigo.
- •Diabetic patients.
研究者
相似试验
已完成
2 期
siddha therapeutic management of attention deficit hyperactivity childreCTRI/2019/07/020161ational Institute Of Siddha30
已完成
1 期
Siddha medicine for HIVCTRI/2008/091/000021daykumar Ranga, JNCASR, Bangalore
尚未招募
2 期
Siddha drug veppampoo Mathirai for Blood pressureCTRI/2022/02/040005Self
尚未招募
3 期
Evaluating therapeutic efficacy of VASANTHAKUSUMAKARAM MATHIRAI for PITHA NEER CHURUKU(Urinary Tract Infection)CTRI/2023/03/050696ational Institute Of Siddha
已完成
2 期
Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in PadarthamaraiTinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are StudiedNCT02238912National institute of Siddha50